| Below - Illustration from Chapter 9: VPI or Volume Portion Index, is a momentum investing indicator that reached a peak on Friday, November 05, 2010. |
 Summary of Recent Reports:No commentary available from weekend report. |
Table of Contents
Volume I: Traditional Analysis of KG:
Chapter 1:
This look at King Pharmaceuticals, Inc. begins with a Classical Time Series Analysis of the historical stock prices, providing a vantage point over patterns that will be explored in greater detail in the following chapters. See KG Classical Analysis.
Chapter 2:
Understanding Price Volatility behaviour is essential to assessing the risk associated with positions across different time spans. See KG Volatility Risk.
Chapter 3:
Historical Volume Trends are analyzed here, revealing seasonal patterns and the influence of the Business Cycle. See KG Historical Volume.
Chapter 4:
A look at Traditional Seasonal Analysis of King Pharmaceuticals, Inc. Historical Prices identifies the best and worst months to be invested. See KG Calendar Year Trends.
Chapter 5:
One of the most popular indicators, the Moving Average, comes in many variations. Here we test the predictive ability of different averages as applied to prediction of King Pharmaceuticals, Inc. prices. See Average Indicators.
Volume II: Modern Technical Analysis:
Chapter 6:
Some say that modern analysis began with the successful identification of technical oscillators such as the highly effective Wilder RSI. See Technical Oscillators.
Chapter 7:
A different type of Seasonal Analysis is applied to KG historical prices. Here the 24 month, November based Political Calendar is the basis for non-standard Seasonal Analysis. See Politics and Prices of KG.
Chapter 8:
Volume Stratification Analysis (or VSA) follows price behavior in relation to historical volumes of KG stock sales. Knowledge of these behaviors gives us a quantitative metric useful for understanding Support or Resistance Levels, and predicting their strength. See Volumetric Analysis.
Chapter 9:
Analysis of Market Momentum as the product of Price and Volume drives an interpretation considerably more sophisticated than those that consider Price Momentum alone. See Momentum Investing Indicators.
Chapter 10:
Technical Analysis discovers the range of moods of investors toward KG. See Market Sentiment.
Section 11:
The chapter first converts the Price Line to several different mappings based on "Runs" or the number of consecutive price movements in a particular direction. A discussion of the "Monte Carlo Fallacy" and it's relevance to Stock Price Prediction leads to a revisionist method of Price Projection using the Bernoulli Analysis. See Bernoulli Run Analysis.
Chapter 12:
The traditional techniques of Candlestick Analysis may seem fanciful, but certain aspects are firmly grounded in the science of Investor Psychology. See Japanese Candlesticks.
Volume III: Advanced Visualization and Prediction:
Chapter 13:
Multi-spectral analysis reveals behavioral features of KG prices that may not be apparent to ordinary analysis. See Support and Resistance.
Chapter 14:
The combination of multi-spectral and mult-dimensional analysis of King Pharmaceuticals, Inc. historical trends, yields a rich set of behavioral surfaces. See Price Behavior Surfaces.
Chapter 15:
Frequency Analysis and Waveform Characterization are applied to the historical prices of King Pharmaceuticals, Inc. in this chapter. See Frequency and Waveform Analysis.
Chapter 16:
Forecasts are gathered from several sources to predict future price movements. See KG Price Predictions.
Volume IV: Final Results and Trading Strategy:
Chapter 17:
The results of various trading strategies carried out over 10 years are evaluated here for KG. The results of "buy and hold", "buy the dips", and other strategies are compared, as well as sliding stop settings. See Single Company Strategies.
Chapter 18:
The trading policies that work well when applied to speculation in any one companies stock may fall short when applied to the more usual situation where a person is speculating on a basket or portfolio of companies. Here we find the best muti-company portfolio trading policies. See KG Multi-Company Strategies .
Appendix A:
The statistical abstract for King Pharmaceuticals, Inc. gathers the most relevant analysis into a single chapter. See KG Final Results . |
| 
Subscribe More than 70 Hi-Rez charts daily for King Pharmaceuticals, Inc.: |
| |
|
